Pathstone Holdings’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$410K Buy
+13,895
New +$357K ﹤0.01% 1970
2025
Q4
Sell
-10,919
Closed -$270K 2226
2025
Q3
$270K Buy
+10,919
New +$244K ﹤0.01% 2068
2025
Q2
Sell
-6,893
Closed -$209K 2190
2025
Q1
$209K Sell
6,893
-8,464
-55% -$322K ﹤0.01% 2065
2024
Q4
$610K Sell
15,357
-16,047
-51% -$724K ﹤0.01% 1639
2024
Q3
$1.99M Sell
31,404
-3,657
-10% -$264K 0.01% 970
2024
Q2
$2.37M Sell
35,061
-1,827
-5% -$128K 0.01% 841
2024
Q1
$2.92M Buy
36,888
+24,923
+208% +$2.04M 0.01% 733
2023
Q4
$930K Buy
+11,965
New +$886K 0.01% 1116

Other funds holding ACHC

Pathstone Holdings's ACHC Position: Q2 2026 in Review

Pathstone Holdings opened a new position in Acadia Healthcare (ACHC) in Q2 2026: 13,895 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #1970 among its holdings. This is a return to the name: Pathstone Holdings previously reported a position in ACHC as recently as Q3 2025.

Pathstone Holdings first reported a position in ACHC in Q4 2023 and has held it in 8 quarters since. The position peaked at $2.92M in Q1 2024. 313 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • Pathstone Holdings held 13,895 shares of Acadia Healthcare worth $410K as of Q2 2026.
  • Acadia Healthcare was a new Pathstone Holdings position in Q2 2026.
  • Acadia Healthcare made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1970 holding.
  • Pathstone Holdings first reported a position in Acadia Healthcare in Q4 2023 and has held it in 8 quarters since.
  • Pathstone Holdings's Acadia Healthcare position peaked at $2.92M in Q1 2024.
  • 313 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.